Patents by Inventor Weizhi GE

Weizhi GE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRIMIDINE TRICYCLIC DERIVATIVE AND PHARMACEUTICAL APPLICATION THEREOF
    Publication number: 20240409560
    Abstract: A pyrimidine tricyclic derivative and a pharmaceutical application thereof. Specifically disclosed are a compound as represented by formula (I), a stereoisomer thereof, and a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: October 13, 2022
    Publication date: December 12, 2024
    Applicant: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Yunfu LUO, Guoli ZHANG, Shaolong LI, Weizhi GE, Shuhui CHEN
  • ALKYL CARBOXYLIC ACID COMPOUNDS AND APPLICATION THEREOF
    Publication number: 20240317696
    Abstract: A series of alkyl carboxylic acid compounds and an application thereof, and relates in particular to compounds represented by formula (II) and a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 10, 2022
    Publication date: September 26, 2024
    Inventors: Yunfu LUO, Weizhi GE, Shaolong LI, Guoli ZHANG, Shuhui CHEN
  • PYRIMIDINE-BASED TRICYCLIC COMPOUND AND USE THEREOF
    Publication number: 20230257398
    Abstract: The present invention relates to a pyrimidine-based tricyclic compound and a use thereof, and specifically, relates to a pyrimidine-based tricyclic compound and a use thereof in preparation of a drug for treating a related disease. Specifically, disclosed are a compound represented by formula (II), a stereoisomer thereof, and a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 29, 2021
    Publication date: August 17, 2023
    Inventors: Yunfu LUO, Guoli ZHANG, Shaolong LI, Weizhi GE, Shuhui CHEN
  • PROTEOLYSIS REGULATOR AND METHOD FOR USING SAME
    Publication number: 20230158152
    Abstract: A proteolysis targeting chimera (PROTAC), and an application thereof in preparation of a drug for treating a related disease. Specifically disclosed are a compound as represented by formula (I) and a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 17, 2021
    Publication date: May 25, 2023
    Inventors: Maoyi LEI, Lei PENG, Yunfu LUO, Yu XU, Junmiao LI, Xinyuan DENG, Zisheng KANG, Weizhi GE, GuoIi ZHANG, Shuhui CHEN